Dr Haolin Liu
Consulting Editor: Haolin Liu (PhD)
Research Associate, Department of Biomedical Research, Howard Hughes Medical Institute at National Jewish Health, Denver, CO, USA
Dr. Haolin Liu is currently a Research Associate in Howard Hughes Medical Institute at National Jewish Health in Denver, CO, U.S.A. He has worked on nanomaterials and influenza virus induced lung cell injury. His work showed that some nanoparticles could induce autophagic cell death by deregulating the AKT-TSC2-mTOR signaling pathway. He has been patented to use autophagy inhibitor for the treatment of such kind of lung injury. He is also an expert in the field of recombinant production of virus protein and making therapeutic antibodies for the treatment of virus infection.